🛡️ Public data only — no PHI permitted on this instance.
SC
SeekingChartis
Investment Committee Memorandum | VA | 25 beds | Grade C | EBITDA uplift $1.1M
Investment Committee Memorandum

SSH - HAMPTON ROADS

CCN 492008 | NEWPORT NEWS, VA | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SSH - HAMPTON ROADS is a 25-bed community hospital in NEWPORT NEWS, VA with $15.2M in net patient revenue and a -1.9% operating margin. The hospital serves a payer mix of 49.5% Medicare, 0.0% Medicaid, and 50.5% commercial.

Thesis: Turnaround. Our ML models identify $1.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -1.9% to 5.4% (+736bps).

Net Revenue HCRIS$15.2M
Current EBITDA COMPUTED$-292K
Operating Margin COMPUTED-1.9%
Occupancy HCRIS90.6%
Revenue / Bed COMPUTED$610K
Net-to-Gross HCRIS20.7%
Distress Probability MLnan%

2. Market Context & Competitive Position

111
VA Hospitals
4.4%
State Median Margin
26
Comparable Hospitals

VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of -1.9% places it below the state median. Among 26 size-comparable peers (12-50 beds), the median margin is 0.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 26 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SSH - HAMPTON ROADS (Target)VA25$15.2M-1.9%
HALIFAX REGIONAL HOSPITALVA44$104.6M-16.5%
WARREN MEMORIAL HOSPITALVA46$97.7M-6.4%
UVA HEALTH HAYMARKET MEDICAL CVA44$95.4M13.4%
SHENANDOAH MEMORIAL HOSPITALVA25$78.2M7.6%
RIVERSIDE DOCTORS HOSPITAL WILVA40$74.0M15.9%
CARILION GILES COMMUNITY HOSPIVA25$72.5M-17.5%
LEWISGALE HOSPITAL-PULASKIVA44$70.4M4.0%
CARILION FRANKLIN MEMORIAL HOSVA37$61.8M-0.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$320K+210bp18mo
Cost to Collect4.5%2.5%$305K+200bp12mo
Denial Rate Reduction12.0%6.5%$302K+198bp12mo
A/R Days Reduction5200.0%3800.0%$185K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$320K
Cost to Collect
$305K
Denial Rate Reduction
$302K
A/R Days Reduction
$185K
Clean Claim Rate
$10K
Total EBITDA Uplift$1.1M
Current EBITDA$-292K
+ RCM Uplift+$1.1M
Pro Forma EBITDA$830K
Current Margin-1.9%
Pro Forma Margin5.4%
WC Released (1x)$585K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-449K$9.3M0.00x-100.0%
Base (11x exit)10.0x11.0x$-449K$10.1M0.00x-100.0%
Bull Case9.0x11.0x$-404K$13.6M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-404K$14.8M0.00x-100.0%
Bear Case11.0x10.0x$-494K$3.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-494K$4.1M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 26 hospitals with 12-50 beds
  • Same-state prioritization (n=27)
  • Comp margins: P25=-11.8% / P50=0.3% / P75=12.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.

Full EBITDA BridgeML AnalysisHospital ProfileStatistical ProfileDeal Screener